Table 1 Comparison of patient groups for CT-RFA and L-RFA for recurrent HCC against the diaphragmatic dome.
Variable | CT-RFA (n = 60) Mean | L-RFA (n = 56) Mean | Comparison p-value |
|---|---|---|---|
Male/Female | 38/22 | 40/16 | 0.3532 |
Age | 53.7 ± 6.8 | 55.2 ± 9.5 | 0.3278 |
Child-Pugh A/B | 35/25 | 34/22 | 0.7943 |
BCLC A/B | 36/24 | 37/19 | 0.4986 |
BMI | 22.8 ± 3 | 23.2 ± 2.9 | 0.4674 |
Lineal Descent Cancer History | 14 (23.3%) | 15 (26.7%) | 0.6680 |
Alcohol Use | 28 (46.7%) | 24 (42.9%) | 0.6801 |
HBs Ag (+) | 50 (83.3%) | 46 (82.1%) | 0.8648 |
Hepatitis C Ab (+) | 2 (3.3%) | 1 (1.8%) | 0.6000 |
Liver Cirrhosis | 41 (68.3%) | 35 (62.5%) | 0.5091 |
Portal Hypertension | 7 (11.7%) | 10 (17.9%) | 0.3463 |
Tumor Number one/two | 46/14 | 35/21 | 0.0967 |
Mean Tumor Size (mm) | 22.4 ± 3.3 | 23.1 ± 3.7 | 0.2838 |
Preoperative Lab Results | |||
ALT (IU/L) | 36.5 ± 14.9 | 30.3 ± 22.6 | 0.0819 |
AST (IU/L) | 35.9 ± 17.0 | 32.4 ± 12.3 | 0.2093 |
Total Bilirubin (μmol/L) | 21.4 ± 5.4 | 19.8 ± 6.1 | 0.1369 |
Albumin (g/L) | 38.1 ± 5.8 | 39.4 ± 3.9 | 0.1623 |
INR | 1.14 ± 0.12 | 1.16 ± 0.11 | 0.3524 |
Platelet count(109/L) | 138.2 ± 56.5 | 126.3 ± 69.0 | 0.3103 |
AFP (<25/≥25 ng/mL) | 38/22 | 43/13 | 0.1147 |
